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Abstract
Itch, the unpleasant sensation that elicits a desire to scratch, is
mediated by specific subtypes of cutaneous sensory neuron. Here,
we identify a subpopulation of itch-sensing neurons based on their
expression of the receptor tyrosine kinase Ret. We apply flow
cytometry to isolate Ret-positive neurons from dorsal root ganglia
and detected a distinct population marked by low levels of Ret and
absence of isolectin B4 binding. We determine the transcriptional
profile of these neurons and demonstrate that they express
neuropeptides such as somatostatin (Sst), the NGF receptor TrkA,
and multiple transcripts associated with itch. We validate the selec-
tive expression of Sst using an Sst-Cre driver line and ablated these
neurons by generating mice in which the diphtheria toxin receptor
is conditionally expressed from the sensory neuron-specific Avil
locus. Sst-Cre::AviliDTR mice display normal nociceptive responses to
thermal and mechanical stimuli. However, scratching behavior
evoked by interleukin-31 (IL-31) or agonist at the 5HT1F receptor is
significantly reduced. Our data provide a molecular signature for a
subpopulation of neurons activated by multiple pruritogens.
Keywords DRG; sensory neurons; IL-31; 5HT1F
Subject Category Neuroscience
DOI 10.15252/embr.201540983 | Received 7 July 2015 | Revised 22 January
2016 | Accepted 26 January 2016 | Published online 29 February 2016
EMBO Reports (2016) 17: 585–600
Introduction
The perception of physical and chemical stimuli through the skin is
initiated by peripheral sensory neurons that have their cell body in
the DRG. The complexity of somatosensation is reflected by the fact
that a myriad of sensations including touch, pain, itch, and tempera-
ture are recognized by the peripheral nervous system. It has long
been debated whether this functional complexity arises from activa-
tion of specific subtypes of sensory neuron for each stimulus
modality, or from encoding and summation of neuronal activity
generated by neurons that can detect a broad range of stimuli [1].
Recently, it has been proposed that the sensation of itch is a discrete
sensory modality that utilizes a dedicated neuronal pathway tuned
to perceive only this sensation [2–4].
Itch, the sensation that elicits a desire to scratch, serves a protec-
tive function against potentially harmful environmental irritants [5].
Although unpleasant, itch is inherently different from pain, both in
its sensory quality and its behavioral outcome (scratching compared
to withdrawal). The neuronal pathways that mediate itch versus
pain also appear to be distinct. In the spinal cord, ablation of
neurons expressing receptors for the neuropeptides, gastrin-
releasing peptide (Grp) [4] or natriuretic polypeptide b (Nppb) [3],
reduces itch responses to multiple pruritogens but does not affect
nociceptive behavior. Similarly, subpopulations of C-fiber primary
afferents are activated by pruritogens [6–8] and ablation or selective
activation of DRG neurons positive for the Mas-related G protein-
coupled receptor A3 (MrgprA3) impacts upon scratching behavior
but not pain [2].
Itch is further categorized by its dependence upon histaminergic
or non-histaminergic mechanisms. Histamine-dependent itch is
elicited through activation of the H1 receptor (HRH1) and signaling
through phospholipase-b3 (PLCb3) and the ion channel TRPV1
[9,10]. The existence of further histamine-independent pathways is
supported by observations that many chronic pruritic syndromes
such as atopic dermatitis are resistant to antihistamine therapy [11].
Mechanistically, histamine-independent itch is likely to be mediated
by activation of the ion channel TRPA1. For example, injection of
the antimalarial agent chloroquine induces itch [12] via MrgprA3
receptors [13] functionally coupled to TRPA1 [14], and TRPA1 is
also required for itch produced by oxidative stress and leukocyte
accumulation [15,16]. Other antihistamine-resistant itch responses
include those elicited by cytokines such as interleukin-31 (IL-31)
released from T cells during allergic itch [17,18]. IL-31 induces
severe pruritus and may be a key mediator in atopic dermatitis [19].
Further information of the molecular profile of itch-sensing
neurons and identification of molecular markers for different
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subtypes of itch neuron would be valuable for understanding how
different pruritogens activate itch pathways. Intriguingly, a recent
study which took an unbiased approach to classify sensory neuron
subtypes identified three populations of putative itch receptors [20].
Each of these populations was enriched for transcripts associated
with itch. However, from their gene expression profile, it was not
clear whether they all signal only itch or can also contribute to other
sensations such as pain.
To distinguish different populations of sensory neuron and
ultimately define their function, we examined the expression
pattern of the glial-derived neurotrophic factor (GDNF) receptor
Ret in mouse DRG. Almost every DRG neuron expresses at least
one neurotrophic factor [21], and approximately 60 percent of
cells are marked by Ret [22]. The Ret tyrosine kinase is the
signaling receptor for GDNF family ligands GDNF, neurturin,
artemin, and persephin which bind via GPI-anchored co-receptors
termed GFRa1–4 to initiate signaling through Ret [23]. Two
distinct waves of Ret expression arise during development with
the first occurring prior to E11.5 and the second emerging sub-
sequently [22,24]. Early Ret-positive neurons develop into rapidly
adapting mechanoreceptors and express the co-receptor GFRa2
and high levels of Ret [25,26]. Late Ret-positive neurons form a
large heterogeneous group of non-peptidergic nociceptors that can
be distinguished by their binding of the plant lectin IB4 [22,24]. A
further population of Ret-positive neuron co-expresses the enzyme
tyrosine hydroxylase (TH) [27,28] and forms C-fiber low threshold
mechanoreceptors which have been implicated in the affective
component of touch [29]. Finally, a fourth population of Ret-positive
neurons that expresses the neurotrophin receptor TrkA in adult mice
has also been described [22,30]. This population is rare, correspond-
ing to around 10% of all Ret cells, and its role in vivo is unknown.
We sought to determine the function of this unique population
of Ret-positive sensory neuron. To this end, we took a genetic
approach and generated mice where eGFP expression was driven
from the Ret locus exclusively in peripheral sensory neurons
[31,32]. We identified multiple subpopulations of Ret-positive
neurons in DRG which were quantified using flow cytometry.
Microarray analysis of Ret-expressing neurons that were negative
for IB4 uncovered a sparse population of cells enriched in tran-
scripts for TrkA, neuropeptides such as somatostatin (Sst), and
pruritogen receptors. We validated the expression of Sst in this
population using an Sst-Cre driver line and generated a new
mouse line to selectively ablate these neurons in vivo. Mice
displayed normal nociceptive responses to thermal and mechanical
stimuli. However, scratching behavior evoked by several classes of
pruritogen was significantly reduced. Thus, Ret marks a population
of itch receptors characterized by their co-expression of Sst and
multiple pruritogen receptors.
Results
Ret-eGFP expression in primary sensory neurons
To examine Ret expression in the adult peripheral nervous system,
ReteGFP/+ mice [31] were crossed with Avilcre/+ [32] mice to obtain
heterozygote Avil-Cre::ReteGFP/+ mice. This approach allowed us to
target all DRG neurons and avoid extraneous GFP expression in
surrounding tissues. Heterozygous mice were viable, exhibited no
overt behavioral phenotype, and displayed robust eGFP fluores-
cence in peripheral sensory ganglia.
We investigated Ret-eGFP distribution in DRG by co-staining
sections from Avil-Cre::ReteGFP/+ mice with a selection of markers
for different subtypes of sensory neuron. Ret-eGFP was present in
55 percent of neurons (Fig 1M) and displayed a broad range of fluo-
rescence intensities across different cells. We examined expression
with IB4 and NF200, markers of non-peptidergic nociceptors and
myelinated neurons, respectively, and observed overlap with the
majority of Ret-eGFP-positive neurons (Fig 1A–D), reflecting the
early and late Ret neurons described previously [22,24]. We further
investigated Ret-eGFP co-expression with TH, a marker of C-fiber
low threshold mechanoreceptors [27,28]. eGFP fluorescence was
evident in many TH-positive neurons and these cells were not co-
labeled with NF200 or IB4 (Fig 1E–L). Our analysis also indicated
that a small proportion of Ret-eGFP-positive neurons were not
marked by either IB4, NF200, or TH, suggesting the existence of a
novel subtype of Ret-expressing neuron. We quantified the overlap
between Ret-eGFP and each marker and determined that 14% of
Ret-eGFP-positive neurons were negative for all markers (Fig 1N),
supporting the idea that this population may reflect a functionally
uncharacterized subset of primary afferent neuron.
We utilized Avil-Cre-driven Ret-eGFP expression to examine the
peripheral and central projections of Ret-positive sensory neurons.
In the skin, Ret-eGFP fluorescence was broadly distributed and
present in free nerve endings terminating in the dermis and epidermis
(Appendix Fig S1), and in lanceolate endings encircling hairs
(Appendix Fig S1). Similarly in spinal cord sections, Ret-eGFP was
widely expressed across the dorsal horn. This was evident as a dense
plexus of expression in lamina IIo corresponding to IB4-
positive non-peptidergic nociceptors (Appendix Fig S2) and more
diffusely through laminae III to V overlapping with NF200-labeled
mechanoreceptor inputs (Appendix Fig S2). Notably, we also detected
Ret-eGFP expression immediately ventral to IB4-positive terminals
that coincided with PKCc, a marker for lamina IIi/III interneurons
(Appendix Fig S2), and in lamina I co-expressed with CGRP. Thus,
RET-eGFP expression distinguishes multiple populations of peripheral
sensory neuron that are likely to be functionally distinct.
To obtain quantitative data on the distribution of Ret-positive
neuronal populations in DRG, we applied flow cytometric analysis
to acutely dissociated neurons. We focused on levels of IB4 bind-
ing and native Ret-eGFP fluorescence as this would allow for
quantitative measurements in live cells. In line with histological
data, we observed both IB4-positive and IB4-negative populations
of Ret-eGFP neuron (Figs 2A and EV1). Importantly, however,
flow cytometric analysis revealed multiple well-defined subpopu-
lations delineated by their levels of eGFP fluorescence and IB4
binding (termed Ret-eGFPLo:IB4Neg (A), Ret-eGFPHi:IB4Neg (B),
Ret-eGFPLo:IB4Lo (C), Ret-eGFPHi:IB4Lo (D), and Ret-eGFPHi:IB4Hi
(E)). There was a broad distribution in cell size across all popula-
tions as determined by forward scatter values, and no correlation
between size and levels of IB4 binding or fluorescence (Fig 2B).
We further validated flow cytometric analysis using fluorescent
microscopy and observed that in both sensory neuron cultures
(Fig 2C) and sections of DRG (Fig 2D) from Avil-Cre::ReteGFP/+
mice, native eGFP fluorescence varied by an order of magnitude
across IB4-positive and IB4-negative cells.
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Figure 1. Ret-eGFP is expressed in multiple sensory neuron subsets.
A–L Ret-positive neurons largely overlap with markers for myelinated neurons (NF200), non-peptidergic nociceptors (IB4), and C-fiber low threshold mechanoreceptors
(TH). However, some Ret-positive neurons are negative for these markers (indicated by the arrows in D, H, and L) suggesting the existence of a further subset of
Ret+ neurons. Scale bars, 50 lm.
M Quantification of the proportion of Ret-eGFP-positive neurons in DRG (n = 2,278 cells from three mice).
N Quantification of Ret-eGFP co-expression with other markers (n = 2,278 cells from three mice).
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Transcription profiling of Ret-eGFP- and IB4-negative neurons
We reasoned that by defining the molecular composition of Ret-
eGFP populations, we may be able to gain clues as to their func-
tion. We focused on IB4-negative neurons because flow cytometric
data indicated that these cells formed two well-defined and poten-
tially homogeneous populations. Moreover, while one of these
populations presumably corresponds to RA mechanoreceptors
[25,26], the other may reflect an as yet uncharacterized population
of Ret-positive neurons. We performed differential microarray
screening on sorted Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg cells
and determined that these two populations do indeed cluster into
distinct, homogeneous subsets. We further identified several func-
tional markers in each population that gave a first indication as to
their identity. For example, Ret-eGFPLo:IB4Neg cells were enriched
in transcripts for TRPV1, CGRP (Calca), and the Ret co-receptors
GFRa1 and GFRa3 (Fig 3A), while Ret-eGFPHi:IB4Neg neurons
expressed significantly higher levels of Ret, GFRa2, and the
mechanosensitive ion channel Piezo 2 (Fam38b) (Fig 3A). Intrigu-
ingly, neither population was enriched for TH. We thus speculate
that Ret-eGFPHi:IB4Neg neurons may correspond to RA mechanore-
ceptors, while Ret-eGFPLo:IB4Neg cells represent a novel, function-
ally distinct subtype of nociceptor.
We sought to define the function of the novel Ret-eGFPLo:IB4Neg
population and observed that this subset was highly enriched in
molecules previously implicated in itch (Fig 3A, red dots). For
example, transcripts for histamine-dependent itch mediators HRH1,
PLCb3, and TRPV1 were all differentially expressed in Ret-eGFPLo:
IB4Neg neurons, as were itch-associated neurotransmitters such as
Nppb [3] and neuromedin B (Nmb) [33], and the co-receptors for
IL-31, Il31ra, and Osmr. However, other molecules implicated in
itch such as GRP, MrgprC11, and endothelin receptors were not
over-expressed in Ret-eGFPLo:IB4Neg neurons, suggesting that these
cells may contribute to a subtype of itch receptor.
To further investigate whether itch-associated receptor tran-
scripts were indeed specifically expressed in Ret-eGFPLo:IB4Neg
neuron, we performed a second microarray screen where we
assessed differential expression in this population with respect to all
DRG neurons. We sorted DRG neurons from Avil-Cre::R26tdRFP mice
in which the majority of peripheral sensory neurons are marked
by RFP fluorescence (Appendix Fig S3) and subjected them to
microarray analysis. Similar to differential screening between
Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg populations, this dataset
was also enriched in itch-associated molecules (Fig 3B). Fold
change levels were lower than for comparisons with Ret-eGFPHi:
IB4Neg neurons (Fig 3C), presumably reflecting the mixed molecular
profile of all DRG neurons, and the fact that some transcripts
such as Calca (CGRP) mark large populations of Ret-negative
neurons.
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Figure 2. Multiple Ret-positive subpopulations as determined by flow
cytometric analysis of dissociated sensory neurons fromAvil-Cre::Ret+/eGFP
mice.
A Flow cytometric analysis of dissociated sensory neurons plotted
according to their level of endogenous Ret-eGFP expression and IB4
binding (also indicated in Fig EV1). There are 5 well-defined subsets, 2 of
which do not bind to IB4 but display a differential level of eGFP intensity
(termed Ret-eGFPLo:IB4Neg, A, and Ret-eGFPHi:IB4Neg, B, respectively). The
other 3 subsets bind IB4 and display a range of eGFP intensities, termed
Ret-eGFPLo:IB4Lo, C, Ret-eGFPHi:IB4Lo, D, and Ret-eGFPHi:IB4Hi, E. Percent
of total events are indicated in each box.
B No correlation between the median cell size of different Ret+ subsets
and eGFP intensity or IB4 binding. The graph shows the forward scatter
values plotted against the normalized number of cells, displayed as the
percent of Max.
C, D Variations in endogenous eGFP intensity are clearly visible with
fluorescent microscopy. (C) Cultured neurons and (D) DRG section from
Avil-Cre::Ret+/eGFP mice displaying native eGFP fluorescence and stained
with IB4. Different levels of eGFP intensity (high, indicated by arrows,
and low, indicated by arrowheads) are detected across IB4+ and IB4
cells. Scale bar, 50 lm.
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Figure 3.
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To validate the microarray analysis, we performed parallel quan-
titative RT–PCR analysis of 38 transcripts in Ret-eGFPLo:IB4Neg and
Ret-eGFPHi:IB4Neg populations using a microfluidic platform (Flu-
idigm). We selected genes that represented not only itch-associated
transcripts but also ion channels, signaling molecules, and transcrip-
tion factors with a demonstrated role in the peripheral nervous
system. In agreement with microarray data, high differential expres-
sion between Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg neurons was
evident for itch-related genes such as the neuropeptide Nppb, the
membrane receptors Il31ra, Osmr, Cysltr2, MrgprA3, and Hrh1, and
the signaling molecule Plcb3. We also observed higher expression in
this population for other markers such as Ntrk1 (TrkA), Calca
(CGRP), and Trpv1 transcripts, marking it as a novel population of
Ret-positive neurons, as well as the ion channels Trpm6, Trpc6,
Trpm2, and P2rx3 and the serotonin receptors Htr1f and Htr1a
(Fig 3D and Appendix Fig S4). In the Ret-eGFPHi:IB4Neg population,
we detected almost 10-fold higher expression of Ret and eGFP, vali-
dating the flow cytometry analysis. In addition, Gfra2 and the
mechanosensitive ion channel Piezo 2 (Fam38b) (but not Piezo 1
(Fam38a)) were upregulated, supporting the assumption that these
neurons function as RA mechanoreceptors. Intriguingly, we also
observed that this population was enriched in transcripts involved
in chloride transport including the GABA channel subunits a1 and
c2 (Gabra1, Gabrg2) and the putative chloride channel anoctamin 6
(Ano6) (Fig 3D and Appendix Fig S4).
SstCre as a surrogate marker for Ret-eGFPLo:IB4Neg neurons
In order to investigate the function of Ret-eGFPLo:IB4Neg neurons,
we required a molecular tool with which to selectively manipulate
this population. From the microarray and quantitative RT–PCR
analysis, the neuropeptide somatostatin (Sst) was among the high-
est enriched transcripts in Ret-eGFPLo:IB4Neg cells, displaying a
1,126-fold higher expression compared to the Ret-eGFPHi:IB4Neg
population. Moreover, an SstCre driver line is available which
has been well characterized in the CNS [34]. We thus examined the
expression pattern of SstCre-mediated recombination in the PNS to
determine whether it coincides with the Ret-eGFPLo:IB4Neg popula-
tion and could be used to genetically target these cells.
We first assessed the anatomical properties of SstCre-positive
neurons by crossing the SstCre driver line with ReteGFP mice to gener-
ate heterozygote Sst-Cre::ReteGFP/+ mice. In DRG sections from these
animals, we detected weak eGFP fluorescence in a sparse popula-
tion of cells corresponding to 1.3% of all neurons (Fig 4I). We
explored this expression pattern in more detail by co-staining
sections with IB4, NF200, and TH (Fig 4A–H). SstCre-driven Ret-
eGFP expression was most evident in neurons not expressing any of
these markers (85% of all Ret-eGFP-positive cells, Fig 4J), suggest-
ing that SstCre may indeed mediate recombination in the Ret-eGFPLo:
IB4Neg population.
To investigate whether SstCre is selective for Ret-eGFPLo:IB4Neg
neurons, we crossed mice with a ubiquitous RFP reporter driven
from the Rosa26 locus (Sst-Cre::Rosa26RFP mice) and performed
immunohistochemistry for neuronal markers on DRG sections. We
again observed a low number of RFP-positive cells (1.8% of total
neurons, Fig EV2) that were mostly negative for IB4 and NF200
(87% of all Rosa26RFP-positive cells, Fig EV2). These values were
not significantly different from the number of Sst-Cre::ReteGFP-
positive neurons (P = 0.36 for total cells and P = 0.7 for marker
negative cells) implying that SstCre does not drive substantial recom-
bination beyond the Ret-eGFPLo:IB4Neg population.
We further examined the peripheral projections of SstCre-positive
sensory neurons using a Rosa26SNAPCaaX reporter mouse line that
allows for highly sensitive detection of Cre-positive cells [35]. We
labeled skin from Sst-Cre::Rosa26SNAPCaax mice with fluorescent
TMR-Star SNAP substrate and observed prominent fluorescence
mainly confined to neurons that formed free nerve endings and ran
parallel to the dermal/epidermal border of the skin (Fig 4K–M). In
occasional sections, we also detected a rare population of hair folli-
cles that were innervated by SstCre-positive neurons (1.9  1% of
hair follicles in 3 out of 13 sections, Fig EV2). Importantly, this stain-
ing pattern was absent from skin taken from control mice not
expressing SstCre.
To obtain a more quantitative assessment of the degree of inter-
section between SstCre-positive neurons and the Ret-eGFPLo:IB4Neg
population, we applied flow cytometric analysis to acutely dissoci-
ated neurons from Sst-Cre::Ret-eGFP mice. We followed an identical
preparation protocol to that performed previously for Avil-Cre::
ReteGFP mice and used the same gates for analysis. In line with histo-
logical data, we observed very few IB4-positive cells among the Sst-
Cre::ReteGFP population, and furthermore, native GFP fluorescence
was low (Fig 5A). Indeed, when comparing this data directly to flow
cytometric analysis of Avil-Cre::ReteGFP neurons (Fig 5B), it was
apparent that four out of the five subpopulations defined in earlier
experiments were absent in SstCre mice and only the Ret-eGFPLo:
IB4Neg was present.
Finally, we sought to validate the identity of SstCre-positive
sensory neurons by assessing their molecular composition
compared to Ret-eGFPLo:IB4Neg cells. We sorted Sst-Cre::ReteGFP
cells using the same gating paradigm as described previously and
Figure 3. Transcriptional profiling of Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg sensory neurons.
A Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg neurons display distinct expression profiles. A volcano plot of fold change expression in Ret-eGFPLo:IB4Neg versus Ret-eGFPHi:
IB4Neg against probability. Ret has higher expression in the Ret-eGFPHi:IB4Neg subset, which also shows an upregulation of the Ret co-receptor Gfra2 and Fam38b,
encoding for the mechanosensitive ion channel Piezo 2. The Ret-eGFPLo:IB4Neg subset displays an array of molecules previously associated with itch (marked in red).
B Itch-associated transcripts are enriched in the Ret-eGFPLo:IB4Neg population compared to all DRG neurons. Volcano plot of fold change expression in Ret-eGFPLo:
IB4Neg neurons versus sorted neurons from Avil-Cre::R26tdRFP mice against probability. Molecules linked to itch perception are significantly upregulated in the Ret-
eGFPLo:IB4Neg subset.
C Gene expression within the Ret-eGFPLo:IB4Neg population is confirmed by triple comparison between Ret-eGFPLo:IB4Neg, Ret-eGFPHi:IB4Neg, and Avil-Cre::R26tdRFP
datasets.
D Validation of differential microarray screening by quantitative RT–PCR. Transcripts encoding ion channels, receptors, neuropeptides, signaling molecules, and
transcription factors were selected for quantitative RT–PCR. Differential expression between Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg populations correlates with
microarray analysis (n = 3).
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Figure 4. SstCre-driven expression in DRG and skin.
A–H SstCre-mediated recombination of the Ret locus drives eGFP expression in sensory neurons that do not bind to IB4 or co-express NF200 or TH. Triple
immunostaining of DRG from Sst-Cre::ReteGFP/+ mice with RetGFP (A), IB4 (B), NF200 (C), RetGFP (E), IB4 (F), and TH (G). Scale bars, 50 lm.
I Quantification of SstCre::Ret-eGFP expression in DRG (n = 8,827 cells from three mice).
J Quantification of co-expression of SstCre::Ret-eGFP with neuronal markers (n = 8,827 cells from three mice).
KM Peripheral projections of sensory neurons from Sst-Cre::Rosa26SnapCaaX mice terminate in the hairy skin as free nerve endings. Non-innervated hair follicles are
indicated by arrows. Double labeling using TMR-Star to label SNAP tag (K) and DAPI (L). Scale bars, 50 lm.
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Figure 5. Flow cytometric and transcriptome analysis of Sst-Cre::ReteGFP versus Ret-eGFPHi:IB4Neg sensory neurons.
A, B Contour diagram of dissociated sensory neurons from Sst-Cre::ReteGFP/+ (A) and Avil-Cre::ReteGFP/+neurons (B), plotted according to their native eGFP expression and
IB4 binding. Only one subset of Ret-eGFP cells can be defined within the Sst-Cre::ReteGFP/+-dissociated DRG neurons. This displays the same range of eGFP
fluorescence as the Ret-eGFPLo:IB4Neg population and does not bind to IB4.
C Quantitative RT–PCR analysis of selected transcripts in the Sst-Cre::ReteGFP (darker colors) and Ret-eGFPHi:IB4Neg (lighter colors) subsets displayed as differential
expression compared to the Ret-eGFPHi:IB4Neg subset. Almost all the genes that are upregulated in the Ret-eGFPLo:IB4Neg compared to the Ret-eGFPHi:IB4Neg subset
are also enriched in the Sst-Cre::ReteGFP population (n = 3).
EMBO reports Vol 17 | No 4 | 2016 ª 2016 The Authors
EMBO reports Molecular profile of a subtype of itch receptors Kalina K Stantcheva et al
592
Published online: February 29, 2016 
subjected cells to quantitative RT–PCR analysis. Strikingly, 36 out of
38 transcripts were regulated in the same direction as Ret-eGFPLo:
IB4Neg relative to Ret-eGFPHi:IB4Neg cells (Fig 5C and Appendix
Fig S5). Furthermore, levels of enrichment for both populations were
remarkably similar, especially for the markers eGFP and Ret, and
for itch-associated transcripts such as Hrh1, Il31ra, Osmr, Cysltr2,
Plcb3, and Nppb (Fig 5C and Appendix Fig S5). Collectively, these
data imply that SstCre does indeed mark the Ret-eGFPLo:IB4Neg
population and that this population is largely homogenous.
Functional characterization of SstCre neurons
To examine the function of SstCre-positive neurons, we reasoned
that selective ablation of this population could uncover their role in
driving distinct somatosensory behaviors. A well-described and
effective method for selectively ablating neurons in vivo involves
Cre-dependent expression of the diphtheria toxin receptor from the
Rosa26 locus and subsequent treatment of animals with diphtheria
toxin [36]. However, because SstCre is expressed widely in the
central nervous system [34], this approach would not be suitable for
deleting only SstCre-positive neurons in the peripheral nervous
system. We thus generated a new mouse line where diphtheria toxin
receptor is integrated into the sensory neuron-specific Avil locus
preceded by a loxP-flanked stop cassette. Crossing these mice with a
Cre driver line should therefore induce expression of the diphtheria
toxin receptor only in peripheral sensory neurons, regardless of
whether Cre is expressed in other tissues.
AviliDTR mice were generated using standard techniques for
knock-in to the Avil locus (Fig EV3). Mice were healthy, displayed
normal fertility, and did not exhibit any obvious defects. To assess
SstCre-mediated recombination of the AviliDTR transgene, SstCre mice
were crossed with AviliDTR animals to produce heterozygote Sst-
Cre::AviliDTR/+ mice, and expression of the diphtheria toxin receptor
determined using immunohistochemistry. In control AviliDTR mice
(without the Cre), we detected no diphtheria toxin receptor expres-
sion. However, in mice with the SstCre allele, a small number of
diphtheria toxin receptor-positive cells were evident in DRG that
was also negative for IB4 (Fig 6A–C and G). We next investigated
the efficiency of ablation of these cells by applying diphtheria toxin
systemically in mice and evaluating the number of diphtheria toxin
receptor cells using immunohistochemistry. We observed an almost
complete loss of diphtheria toxin receptor immunoreactivity after
toxin application (Fig 6D–F). To determine whether ablation also
impacts upon endogenous Sst expression and does not affect other
populations, we performed immunocytochemistry on dissociated
DRG neurons plated on glass coverslips and labeled with Sst and
NF200 antibodies, and IB4. Sst-Cre::AviliDTR/+ mice treated with
diphtheria toxin displayed a complete loss of Sst immunoreactivity
with no change in the number of NF200- or IB4-positive neurons
(Fig EV4). Finally, we carried out quantitative RT–PCR on Sst and
other transcripts associated with the Ret-eGFPLo:IB4Neg population
(Hrh1, MrgprA3, Il31ra, and Htr1f). All transcripts were strongly
downregulated upon diphtheria toxin-mediated ablation (Fig EV4),
indicating that this strategy is an effective means of eliminating the
SstCre population in vivo.
To explore the function of SstCre-positive cells, we initially
performed calcium imaging on acutely dissociated DRG and investi-
gated their activation by pruritogens. Based upon transcriptome
analysis, we selected four receptor classes highly enriched in this
population encompassing histamine-dependent (histamine) and
histamine-independent signaling (chloroquine and IL-31), and a class
of receptor, 5HT1F not previously implicated in itch, but which
couples to the inhibition of adenylate cyclase [37] and may therefore
inhibit neuronal activity. Experiments were carried out on DRG from
control AviliDTR mice and Sst-Cre::AviliDTR mice, both treated system-
ically with diphtheria toxin. Application of histamine to cells evoked
a characteristic phasic calcium response in approximately 10% of
neurons from control mice, which upon ablation was reduced to less
than 1% (Fig 6H and L). Chloroquine and IL-31 activated a similar
number of neurons in control mice with a corresponding decrease in
the number of responsive cells in DRG from Sst-Cre::AviliDTR mice
(Fig 6I, J and L). Finally, we examined the function of the 5HT1F
receptor by applying the 5HT1F agonist LY344864 to neurons. Unex-
pectedly, we found that application of low concentrations of
LY344864 evoked calcium flux in a small population of neurons that
was also reduced upon ablation of SstCre neurons (Fig 6K and L). In
all cases, responses to pruritogens which remained after ablation
were quantitatively similar to those from control cultures (Fig EV4).
The AviliDTR strategy opens up the possibility to determine how
ablation of the SstCre population impacts upon mouse behavior, and
thus translate in vitro observations in DRG to events occurring in
sensory neuron endings in the skin. To explore this, we first exam-
ined nociceptive thresholds in control AviliDTR and Sst-Cre::AviliDTR
mice treated with diphtheria toxin. We observed no significant
difference in thermal withdrawal thresholds in the hot plate test
(P = 0.17, Fig 7A) or mechanical thresholds to calibrated von Frey
filaments (P = 0.32, Fig 7B). We next considered responses to pruri-
togens by quantifying scratching behavior after intradermal injec-
tion of agonists tested in isolated DRG. We first assayed responses
in control (AviliDTR) and Sst-Cre::AviliDTR mice in the absence of
diphtheria toxin. All compounds including the 5HT1F agonist
LY344864 evoked robust scratching behavior compared to vehicle
(Figs 7C–F and EV5). We then applied diphtheria toxin systemically
to these mice and reexamined scratching responses. Strikingly, we
observed a significant reduction in scratching behavior in Sst-Cre::
AviliDTR mice evoked by IL-31 and LY344864, but not by histamine
or chloroquine (Figs 7C–F and EV5). Responses in control AviliDTR
mice were not influenced by diphtheria toxin application, indicating
that SstCre neurons (and thus the Ret-eGFPLo:IB4Neg population)
mediate itch sensation in vivo.
Discussion
Here, we show that a previously uncharacterized population of
sensory neurons that express the receptor tyrosine kinase Ret func-
tion as itch receptors. Using flow cytometry of dissociated DRG
neurons, we isolated this population based upon its weak expres-
sion of Ret and absence of IB4 binding. We demonstrate that these
neurons express markers such as TrkA and Sst, and importantly are
highly enriched for transcripts associated with itch sensation.
Anatomical and functional analysis of these cells indicates that they
form a rare subtype of DRG neuron and function to detect itch
inducing stimuli.
Three populations of Ret-positive sensory neuron have been
previously identified and characterized. Early Ret neurons develop
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Figure 6. Diphtheria toxin-mediated ablation of SstCre-positive DRG neurons.
A–G Ablation of Sst-Cre::AviliDTR-positive sensory neurons by injection of diphtheria toxin (DTX). Immunostaining of DRG from Sst-Cre::AviliDTR mice with an antibody
against the diphtheria toxin receptor and IB4 in the absence of diphtheria toxin (A–C) and after systemic injection of diphtheria toxin (D–F). (G) Quantification of
diphtheria toxin receptor-positive neurons before and after injection of diphtheria toxin.
H–K Examples of calcium flux in dissociated DRG upon application of histamine (H), chloroquine (I), IL-31 (J), and 5HT1F agonist Ly344864 (K).
L Quantification of percent responding neurons to the indicated pruritogens before or after systemic injection of diphtheria toxin in Sst-Cre::AviliDTR mice.
Data information: Scale bars, 50 lm. Asterisk denotes P < 0.05, n = 4–6 mice, Student’s t-test, error bars indicate SEM.
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Figure 7. Reduced scratching behavior in Sst-Cre::AviliDTR mice after diphtheria toxin-mediated ablation.
A, B Nociceptive withdrawal thresholds in control (AviliDTR without the Cre) and Sst-Cre::AviliDTR mice after systemic diphtheria toxin injection. No significant differences
in thermal (A) or mechanical (B) withdrawal reflexes after ablation of SstCre-positive neurons.
C–F Scratching behavior after a single intradermal injection of the indicated pruritogen observed for 1 h. All compounds evoked a significant increase in the number of
scratching bouts compared to vehicle alone in control (AviliDTR) or Sst-Cre::AviliDTR mice. Diphtheria toxin injection in control mice (AviliDTR) had no effect on
scratching behavior evoked by histamine (C), chloroquine (D), IL-31 (E), or 5HT1F agonist Ly344864 (F) but significantly reduced responses to IL-31 or Ly344864 in
Sst-Cre::AviliDTR mice.
Data information: n numbers indicated in brackets, and asterisk denotes P < 0.05, two-way RM ANOVA, Holm–Sidak multiple comparison. Error bars indicate SEM.
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into RA mechanoreceptors [25,26], while late Ret neurons become
C-fiber low threshold mechanoreceptors and non-peptidergic noci-
ceptors [22,28]. Intriguingly, a fourth population of Ret-positive
neurons has also been described that expresses TrkA in adult mice
but has unknown function [22,30]. This population is scarce,
corresponding to around 10% of all Ret-positive cells [22,30], and
presumably this rarity has made further analysis difficult. By taking
advantage of the sensitivity and analytic power of flow cytometry,
we have isolated these cells and performed gene expression profiling
to determine their function.
We initially used histochemistry to identify populations of
Ret-eGFP-positive neuron expressing markers of mechanoreceptors
(NF200), non-peptidergic nociceptors (IB4), and C-fiber low
threshold mechanoreceptors (TH). However, limited by the number
of markers that can be applied simultaneously to the same section,
we turned to flow cytometry to analyze Ret expression in more
detail. We based our analysis on the observation that Ret expression
levels differ considerably across the DRG and that low Ret levels
correlate with GFRa1/3 expression [24], while high Ret-expressing
neurons express GFRa2 and form RA mechanoreceptors [25,26]. By
co-labeling cells with IB4, we were able to distinguish multiple
subtypes of Ret-positive neurons of which a Ret-low, IB4-negative
population was clearly evident. That this population corresponds to
the fourth, uncharacterized type of Ret neuron is supported by
several lines of evidence. Firstly, it is IB4 negative, indicating that it
is not part of the non-peptidergic nociceptor population. Secondly, it
expresses almost 10-fold less Ret transcript compared to Ret-eGFPHi:
IB4Neg neurons. Thirdly, Gfra3 is upregulated 29-fold in these cells,
while Gfra2 has 21-fold higher expression in the Ret-eGFPHi:IB4Neg
population. Finally, we detected many differentially expressed genes
such as TrkA, CGRP, and TRPV1, in the Ret-eGFPLo:IB4Neg popula-
tion which are known to be absent from C-LTMRs or RA
mechanoreceptors [28]. While we did not perform a similar analysis
on IB4-positive neurons, flow cytometry data indicate that further
three populations can also be differentiated here which may also
form distinct functional populations.
Given the powerful regulatory actions of neurotrophic factors in
the peripheral nervous system, a major emphasis of previous
research has been to investigate how deletion of these factors
impacts upon the survival, differentiation, and maintenance of
distinct populations. Here, we have not considered the effects of Ret
ablation on Ret-eGFPLo:IB4Neg-negative neurons, concentrating
instead upon the initial functional characterization of this popula-
tion. Of note, the number of Ret-positive/TrkA-positive neurons is
not reduced in Ret nociceptor-specific conditional knockout mice
[30], suggesting that this population does not require Ret for its
survival. It is, however, possible that the termination pattern of
these neurons in the skin and spinal cord, and the expression of ion
channels and signaling molecules are regulated by Ret signaling as
has been shown for other populations [22,24–28,30,38]. The
identification of markers and molecular tools with which to target
Ret-eGFPLo:IB4Neg-negative cells described here would now allow
for further investigation of these phenotypes.
Among the differentially expressed genes present in Ret-eGFPLo:
IB4Neg cells, we observed a strong enrichment of the neuropeptides
CGRP, Nppb, neurotensin (Nts), and somatostatin (Sst). Of these,
we focused our attention on Sst because of the availability of an
Sst-Cre driver line [34] which we reasoned could be used to target
the Ret-eGFPLo:IB4Neg population. Indeed, recombination of the Ret
or Rosa26 locus by Sst-Cre occurred in very few neurons of the
DRG, resulting in fluorescence in mainly IB4- and NF200-negative
cells, analogous to the Ret-eGFPLo:IB4Neg population. Moreover,
flow cytometry analysis and transcriptional profiling revealed that
these neurons overlap. Of note, Sst-Cre-mediated recombination of
eGFP and RFP reporters resulted in a lower number of positive cells
when compared to the Ret-eGFPLo:IB4Neg population, or to antibody
staining of Sst. We suggest that this may be due to the lower sensi-
tivity of reporter fluorophores [35]. Indeed, in ablation experiments
which require minimal expression of the diphtheria toxin receptor
to induce cell death, we observed around 10% reduction in the
number of cells responding to pruritogens such as histamine.
To define the function of the Sst-Cre/Ret-eGFPLo:IB4Neg popula-
tion, we generated a new mouse line which allows for selective
ablation of Cre-positive sensory neurons regardless of whether Cre
recombinase is expressed in other tissues beyond the DRG. Using
this mouse, we were able to selectively ablate Sst-positive neurons
and found that both cellular and behavioral responses to prurito-
gens but not nociceptive behavior were reduced upon ablation.
Intriguingly, we also observed several differences between in vitro
studies on isolated DRG and in vivo studies examining scratching
behavior. For example, histamine- and chloroquine-evoked
responses were sensitive to diphtheria toxin ablation in isolated
DRG, but were not affected at the whole animal level. One possible
explanation for this discrepancy is that ablation of Sst-Cre-positive
neurons does indeed eliminate those neurons which respond
directly to the tested pruritogens. However, in vivo, alternative path-
ways involving other cell types may be evoked (especially by hista-
mine and chloroquine) which in turn activate a broader spectrum of
neurons to trigger scratching. It was also unexpected that scratching
behavior was only partially reduced in vivo. Indeed, knockout mice
for Nbbp show an almost complete loss of itch-evoked behavior [3],
and Nbbp was highly upregulated in Ret-eGFPLo:IB4Neg neurons and
is co-expressed with Sst [29,30]. Since our data indicate that Sst
neurons are fully ablated upon treatment with diphtheria toxin
(Fig EV4), this would suggest that Nbbp is also expressed outside of
the Sst population. Thus, the AviliDTR mouse line may be a useful
tool for establishing functional overlap between different popula-
tions of sensory neuron.
We were intrigued by the high expression levels of the serotonin
receptors Htr1f and Htr1a in Ret-eGFPLo:IB4Neg neurons. Serotonin
has a well-established pruritogenic action when applied subcuta-
neously and this effect is mediated by 5-HT2 receptors [40,41]. Tran-
scripts for 5-HT2 receptors were not upregulated in Ret-eGFP
Lo:
IB4Neg cells and we did not investigate further whether serotonin
directly activates these cells. Instead, we focused on the 5HT1F
receptor because it is coupled to Gi signaling and should therefore
inhibit neuronal activation. Unexpectedly, we observed an apparent
activation of Ret-eGFP/IB4-negative sensory neurons by the 5HT1F
agonist LY344864 and robust scratching behavior when LY344864
was injected intradermally in control animals. A potential basis for
this effect may come from the observation that many Gi-coupled
receptors are able to interact with G14 subunits promoting the stimu-
lation of phospholipase C [42]. Indeed, the transcript for G14
(Gna14) was among the most differentially expressed genes in
Ret-eGFPLo:IB4Neg neurons (Fig 5A–C), and thus, its presence could
expand the signaling repertoire of these cells allowing for Gi-coupled
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receptors such as 5HT1F to generate neuronal activity. Of note,
5HT1F receptor agonists have also been proposed as clinical targets
for the treatment of migraine [43]. Our data indicate that these
compounds could have unwanted side effects via activation of Sst-
Cre/Ret-eGFPLo:IB4Neg neurons and generation of itch.
In addition to the four pruritogen receptors examined here,
many molecules previously implicated in itch sensation such as
Cysltr2, Plcb3, and Nppb were enriched in the Ret-eGFPLo:IB4Neg
population. However, other itch-associated transcripts were absent
from the transcriptome data including GRP, MrgprC11, endothelin
receptors, and TSLP receptor transcripts (Il7r and Crlf2) which
play a critical role in the development of atopic dermatitis [44].
These data support the recent finding that several populations of
putative itch receptors exist in the mouse which may be tuned to
selectively detect the multitude of irritants which can evoke
scratching behavior [20]. Our data on the expression profile of
Ret-eGFPLo:IB4Neg neurons provide a molecular inventory for one
of these populations, and as such many more molecules with an
as yet unexplored role in itch may be contained within this list.
Moreover, this complexity suggests that therapeutic strategies for
treating itch should target common signaling molecules or disrupt
neuronal function, rather than inhibit specific receptors. The tran-
scriptional profiling approach described here is a first step toward
identifying these molecules.
Materials and Methods
Transgenic mouse lines
To study Ret expression in adult primary sensory neurons, we
crossed RETeGFP/+ [31] mice with the DRG neuron-specific Cre line
Avilcre/+ [32] to obtain Avil-Cre::RETeGFP/+ mice. We also used the
Avilcre/+ line to mark sensory neurons within the DRG by crossing
it with a Rosa26tdRFP strain [45] to generate Avil-Cre::R26tdRFP/+
mice. To specifically mark Ret-eGFPLo:IB4Neg neurons, we bred
Sstcre/+ [34] and RETeGFP/+ mice, thus obtaining Sst-Cre::ReteGFP/+
animals. To mark all Sst-positive neurons, we crossed the SstCre
line with the above-mentioned Rosa26tdRFP strain, generating Sst-
Cre::R26tdRFP/+ mice. To visualize Sst-positive nerve endings, the
SstCre/+ mice were bred with Rosa26SnapCaaX/+ animals [35] to
obtain Sst-Cre::Rosa26SnapCaaX/+ offspring.
To ablate Sst-positive sensory neurons, we crossed the SstCre line
with an AviliDTR line, thus obtaining Sst-Cre::AviliDTR/+ mice that
express the diphtheria toxin receptor specifically in Sst-positive DRG
neurons.
The AviliDTR line was obtained by classical knock-in of the iDTR
cassette Lox-STOP-Lox-DTR (kindly provided by the Waisman
group in Mainz) into the Avil locus, to replace exon 2 and 66 bp
upstream thereof (Fig EV3). The targeting construct was transfected
into A9 ES cells. Individual ES cell clones underwent Southern blot
screening to identify homologous recombinants. DNA was digested
with PstI and HindIII and hybridized with 50 or 30 probe, respec-
tively, obtaining 9,600 (wild-type)- and 6,300 (targeted)-bp DNA
fragments by using the 50 probe and 7,100 (wild-type)- and 5,600
(targeted)-bp DNA fragments by using the 30 probe. Positive clones
were injected into 8-cell stage embryos to generate mice hetero-
zygous for the targeted allele. To assess mouse genotype, PCR was
performed with the following primers: aggagcgagggctcagttgggctgt
(forward) and acaccaggttagcctttaagcctgc (reverse) for the wild-type
and ctgccacccaggttaccatggagagagg (forward) and cattctagttgtggtttgtc
caaactca (reverse) for the mutant allele, giving PCR products of 313
and 287 bp, respectively. Heterozygous mice were all viable and
exhibited no overt behavioral phenotype.
All mice were bred and maintained at the EMBL Mouse Biology
Unit, Monterotondo, in accordance with Italian legislation (Art. 9,
27. Jan 1992, no 116) under license from the Italian Ministry of
Health, and in compliance with the ARRIVE guidelines. The AviliDTR
conditional allele has been deposited in the European Mutant Mouse
Archive (www.emmanet.org).
Immunofluorescence
DRG and spinal cord from adult mice (6 weeks or older) were post-
fixed in 4% PFA for 30 min (DRG) or 2 h (SC), embedded in 12%
bovine gelatin, and sectioned using a vibratome at 50–100 lm.
Sections were incubated for 30 min in 50% ethanol and then over-
night in 0.3% Triton X-100, and 5% goat or donkey serum in PBS at
4C containing one or more antibodies diluted as shown below.
Secondary antibodies and streptavidin-647 were diluted (1:1,000
and 1:600, respectively) in 0.3% Triton X-100, 5% goat or donkey
serum in PBS and left for 1–2 h at 4C. Slides were mounted with
Prolong gold antifade (Invitrogen, P36930).
For immunofluorescence analysis of the Avil-Cre::RETeGFP/+
mouse skin, the hair was removed and skin collected and postfixed
in 4% PFA for 8–12 h, incubated in 30% sucrose overnight, and
frozen in OCT. 35-lm sections were cut with a cryostat. Antibody
staining was performed as described above.
For SNAP-tag analysis of the Sst-Cre::Rosa26SnapCaaX/+ mouse
peripheral nerve endings, the back skin of the animals was injected
intradermally with 10 lM of Snap-Cell TMR-Star (New England
Biolabs, S9105S). After 6 h, the skin was collected and treated as
described above. Once sectioned, the skin was additionally stained
with DAPI (Invitrogen, D1306).
We used the following primary antibody dilutions: mouse anti-
NF200 (Sigma Aldrich, N0142) 1:500, goat anti-CGRP (Santa Cruz,
SC8856) 1:500, rabbit anti-PKCc (Santa Cruz, SC-211) 1:100,
isolectin GS-B4-biotin XX conjugate (Invitrogen I21414) 1:100, rabbit
anti-RFP (Rockland, 600-401-379) 1:200, rabbit anti-TH (Millipore,
AB152) 1:1,000, rabbit anti-PGP9.5 antibody (Dako, Z5116) 1:200.
To visualize the cells expressing the diphtheria toxin receptor,
we used goat anti-human HB-EGF antibody (R&D Systems, AF-259-
NA).
Sst, NF200, and IB4 staining was performed on acutely dissoci-
ated neurons from Sst-Cre::AviliDTR/+ and control AviliDTR/+ (with-
out the Cre), after treatment with diphtheria toxin. Cells were
dissociated with 1 mg/ml collagenase IV and 0.05% trypsin (Gibco,
25300-054) for 25 min each at 37C and subsequently plated on
glass coverslips treated with poly-L-lysine. Cells were fixed with 4%
PFA for 5 min and permeabilized 10 min with 0.1% Triton X-100/
PBS. Blocking with 3% normal goat serum in 0.01% Tween-20/PBS
was performed for 20 min and cells were then stained overnight at
4C with rat anti-Sst (1:50 concentration, MAB354, Millipore),
mouse anti-NF200 (1:1,000), and IB4 (1:100). After washing with
PBS, secondary antibody staining was performed for 1.5 h. Glass
coverslips were then mounted with Prolong gold antifade.
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All images were visualized with a Leica SP5 confocal microscope
and analyzed with ImageJ.
Flow cytometry and microarray analysis
To quantitatively analyze the distribution of Ret+ sensory neurons
in DRG, we used flow cytometry on Avil-Cre::RETeGFP/+ mice: DRG
were collected from 10 adult Avil-Cre::RETeGFP/+ mice (6 weeks
or older) and pooled. Cells were dissociated with 1 mg/ml
collagenase IV and 0.05% trypsin (Gibco, 25300-054) for 25 min
each at 37C and subsequently kept on ice in 1% FBS in PBS.
Cells were labeled in suspension with 1:50 anti-mouse CD16/32
(eBioscience 14-0161-85) for 5 min and isolectin GS-B4-biotin XX
conjugate (1:100) for 10 min. After washing, cells were incubated
immediately with a cocktail containing streptavidin-Alexa 647 and
anti-CD45-PeCy7 for 5 min, washed, and resuspended in 1% FBS
in PBS.
To isolate the whole sensory neuron population, we applied flow
cytometric analysis and subsequent sorting on Avil-Cre::R26tdRFP/+
mice: DRG were collected from three adult Avil-Cre::R26tdRFP/+ mice
(6 weeks or older) and pooled. Cell dissociation was performed as
described above. Cells were then labeled in suspension with 1:50
anti-mouse CD16/32 (eBioscience 14-0161-85) for 5 min, and after
washing, cells were incubated in anti-CD45-PeCy7 (1:200) for
5 min, washed, and resuspended in 1% FBS in PBS.
To analyze the distribution of Ret- and Sst-positive sensory
neurons, we used flow cytometry on Sst-Cre::ReteGFP/+ animals.
Sensory neurons from 10 mice were collected, isolated, and stained
following the same protocol used for the analysis of Avil-Cre::
RETeGFP/+ mice.
Flow cytometric online and offline analyses were performed in
a FACS Aria III SORP (BD Bioscience) using FACS Diva software
(BD Bioscience) and FlowJo (Tree Star, Inc.), respectively. For
gene expression analysis, DRG cells were sorted (see Fig EV1)
using an 85-lm nozzle (40 PSI) directly into RLT buffer (RNeasy
kit, Qiagen) and RNA was purified according to manufacturer
instructions. Two rounds of RNA amplification, labeling, and
hybridization to Affymetrix MOE430 2.0 GeneChip expression
arrays were performed by the EMBL Gene Core Facility. Microar-
ray data were analyzed as detailed in the Appendix. All data have
been submitted to ArrayExpress with the accession code E-MTAB-
1836.
Fluidigm
To validate the microarray data, we used the microfluidic platform
Fluidigm to perform quantitative RT–PCR. DRG from Avil-Cre::
RETeGFP/+ mice were collected and processed as described above.
Cells were sorted directly into 5 ll of CellsDirect (Invitrogen, PN
11753-100 and 11753-500) 2× Buffer, and combined with 0.2 ll of
RT/Taq mix, 1 ll of assay pool (formed by 38 individual assay pairs
that were previously pooled and diluted to a final concentration of
500 nM), and 2.8 ll of water. The samples went through target-
specific RT and pre-amplification (16 cycles) following manufacturer
instructions. Pre-amplified cDNA was then diluted 1:10 and
combined together with 2.5 ll 2× SsoFast Evagreen Supermix (Bio-
Rad, PN 172-5211) and 0.25 ll 20× Sample Loading Reagent (Flu-
idigm, PN 100-0388) and loaded onto the sample inlets of a 48.48
Fluidigm Dynamic Array. All 38 individual assays pairs (100 lM)
were diluted by combining 0.25 ll of each assay with 2.25 ll of TE
Buffer (TEKnova, PN T0224) and 2.5 ll of Assay Loading Reagent
(Fluidigm, PN 85000736). The 48.48 chip was then loaded on the
IFC Controller MX and 30 cycles of qPCR were performed on the
Fluidigm BioMark HD system. Data were analyzed using Fluidigm
Real-Time Analysis Software.
To compare the level of expression of the 38 genes between
Ret-eGFPLo:IB4Neg- and Sst-Cre::ReteGFP-positive sensory neurons,
we used Fluidigm platform to perform qRT–PCR on DRG neurons
sorted from Sst-Cre::ReteGFP/+ animals. We followed the same
procedure described above.
qRT–PCR
DRG were dissected from adult Sst-Cre::AviliDTR/+ and control
AviliDTR/+ (without the Cre) mice treated with 40 lg/kg of diphthe-
ria toxin (2 injections, the second injection occurring 72 h after the
first one). Mice were sacrificed 8 days after the second DTX injec-
tion. RNA was isolated using Trizol and reverse-transcribed using
Superscript II (Invitrogen). Quantitative RT–PCR was then
performed with LightCycler 480 SYBR Green I Master kit (Roche,
04707516001) following manufacturer instructions and using Roche
LightCycler 480 instrument. The expression of each gene was calcu-
lated relatively to ubiquitin using the 2DDCt method.
Calcium imaging
DRG from adult Sst-Cre::AviliDTR/+ and control AviliDTR/+ (without
the Cre) mice were collected and incubated in 1 mg/ml collagenase
IV (Sigma Aldrich, C5138) and 0.05% trypsin (Gibco, 25300-054)
for 25 min each at 37C. They were then suspended in DRG medium
(DMEM (Gibco, 41966-029) with the addition of 10% heat inacti-
vated FBS (PAA, A15101), 0,8% glucose and 100 U of penicillin/
streptomycin (Gibco, 15140-122)). Cells were plated in a droplet of
medium on glass coverslips treated with poly-L-lysine and left to
attach for 3 h at 37C.
Cells were then incubated in 3 lM Fura2-AM (Invitrogen, F1221)
in CIB (140 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
4.55 mM NaOH, 5 mM glucose, 10 mM HEPES, pH 7.4) and
calcium imaging was performed as described [46]. Concentrations
of compounds used were as follows: histamine, 1 lM (Sigma,
H7250); LY344864, 30 nM (Abcam, ab120592); IL-31, 2 nM (Pepro-
tech, 210-31); chloroquine, 500 lM (Sigma, C 6628).
Behavior
To evaluate the scratching response of animals prior and after abla-
tion of the Sst-positive sensory neurons, we removed the hair of the
neck of 6- to 8-week-old Sst-Cre::AviliDTR/+ and control AviliDTR/+
mice with an electric shaver. The animals were acclimatized for
2–3 days and the following day they were injected intradermally
with 50 ll solution in the nape of the neck with one of the following
reagents: 10 mM histamine (Sigma, H7250) in saline, 1 mM
LY344864 (Abcam, ab120592) in saline, 5.6 lM IL-31 (Peprotech,
210-31) in 0.1% BSA/PBS, 12.5 mM chloroquine (Sigma, C 6628) in
saline. Control injections were performed with appropriate vehicle.
Animals were observed for 60 min and bouts of scratching counted.
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One bout was defined as an event of scratching lasting from when
the animal lifted the hind paw to scratch until it returned it to the
floor or started licking it.
The actual time of scratching was also assessed, considered as
the time from when the animal started scratching until it put its hind
paw down.
The same animals were then injected i.p. with 40 lg/kg of DTX
(Sigma D0564). After 72 h, a second injection of DTX was
performed. After 5 days, mice were again acclimatized for 2–3 days,
and at the 8th day after the second DTX injection, scratching
behavior was assessed again, using the same reagent of the first test,
at the same concentration.
For the hot plate and the von Frey tests, Sst-Cre::AviliDTR/+
and AviliDTR/+ (without the Cre) mice were injected twice with
40 lg/kg of DTX, with the second injection occurring 72 h after the
first one. The tests were performed 8 days after the second DTX
injection, after 2–3 days of acclimatization.
For the hot plate test, each animal was placed on the hot plate
(Ugo Basile) and left to acclimatize for 30 min. A gradient from 42
to 49°C was applied and stopped as soon as a paw withdrawal or
licking was observed. This was repeated for 2–3 days. On the day of
the actual test, animals were placed again on the hot plate and the
gradient was applied: The temperature at which a paw withdrawal
or licking was observed was registered as individual threshold for
thermal nociception.
For the von Frey test, animals were acclimatized by placing them
in cages on a mesh platform and by applying von Frey filaments
(North Coast Medical) on the plantar surface of the hind paw. The
actual test was performed following the simplified up–down method
proposed by Bonin et al [47].
Sample sizes were determined from the power of the statistical
test performed. No animals were excluded and all experiments were
performed blinded with order of testing randomized.
Expanded View for this article is available online.
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